ObvioHealth Is Ready For Decentralized Trials To Continue Growth Post-Pandemic
Executive Summary
ObvioHealth is redefining clinical trials with its remote approach to address poor-quality patient-reported data and high costs while simultaneously discovering new trial outcomes.
You may also be interested in...
ObvioHealth Is Building A New Digital Ecosystem To 'Revolutionize' Trials
Using artificial intelligence and strict data collection protocol, ObvioHealth hopes to digitize clinical trials with the assistance of medical devices and consumer technology.
Moving Pharma Execs Out Of The Shadows Is Key To Building Public Trust
2024 Rising Leader, Jack O’Meara, says the industry must ‘promote personalities’ when building new biotech businesses to gain the trust of investors and the public.
Deals Shaping The Industry, February 2024
An interactive look at pharma, medtech, and diagnostics deals made during February 2023. Data courtesy of Biomedtracker.